Herbst A, Bystryn J C
Ronald O. Perelman Department of Dermatology, New York University Medical Center, 10016, USA.
J Am Acad Dermatol. 2000 Mar;42(3):422-7. doi: 10.1016/s0190-9622(00)90213-5.
The incidence of remissions in pemphigus is unclear because these are usually reported at a single point in the evolution of the disease. Thus it is uncertain whether treatment simply suppresses the manifestations of the disease and consequently must be continuously administered, or induces complete and long-lasting remissions that permit therapy to be discontinued.
To answer this question, we investigated the incidence of remission in a long-term longitudinal study.
The induction of complete and long-lasting remissions (lesion free with no systemic therapy for at least 6 months) was studied in 40 patients with pemphigus vulgaris treated conventionally and followed up for an average of 7.7 years by the same investigator.
Five (5%) of the patients died of the disease. Complete and long-lasting remissions were induced in 25%, 50%, and 75% of patients 2, 5, and 10 years, respectively, after diagnosis. Most of the remaining patients were in partial remission or had mild disease controlled with a small dose of steroids. The course of the disease followed different patterns, with some patients rapidly entering complete and long-lasting remissions, whereas others never entered into a complete remission. The induction of complete remission was related to the initial severity and extent of disease and to early response to treatment.
It is possible to eventually induce complete and durable remissions in most patients with pemphigus that permit systemic therapy to be safely discontinued without a flare in disease activity. The proportion of patients in whom this can be achieved increases steadily with time, and therapy can be discontinued in approximately 75% of patients after 10 years.
天疱疮缓解的发生率尚不清楚,因为这些通常是在疾病演变过程中的单个时间点报告的。因此,不确定治疗是仅仅抑制了疾病的表现,因此必须持续给药,还是诱导了完全且持久的缓解从而允许停止治疗。
为了回答这个问题,我们在一项长期纵向研究中调查了缓解的发生率。
对40例接受传统治疗的寻常型天疱疮患者进行了完全且持久缓解(无皮损且至少6个月未进行全身治疗)的诱导研究,由同一位研究者平均随访7.7年。
5例(5%)患者死于该病。分别在诊断后2年、5年和10年,25%、50%和75%的患者诱导出了完全且持久的缓解。其余大多数患者处于部分缓解状态或疾病通过小剂量类固醇得到控制。疾病进程呈现不同模式,一些患者迅速进入完全且持久的缓解状态,而另一些患者从未进入完全缓解状态。完全缓解的诱导与疾病的初始严重程度和范围以及对治疗的早期反应有关。
在大多数天疱疮患者中最终有可能诱导出完全且持久的缓解,从而允许安全地停止全身治疗而不会出现疾病活动的复发。能够实现这一点的患者比例随时间稳步增加,10年后约75%的患者可以停止治疗。